Cadrenal Therapeutics, Inc.
CVKD
$1.19
-$0.01-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.54M | -11.89M | -13.24M | -14.39M | -14.11M |
| Total Depreciation and Amortization | 2.10K | 2.00K | 6.90K | 6.70K | 6.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.72M | 1.64M | 1.94M | 2.38M | 2.20M |
| Change in Net Operating Assets | -343.60K | -712.00K | -1.31M | 178.50K | 230.00K |
| Cash from Operations | -10.16M | -10.96M | -12.60M | -11.82M | -11.67M |
| Capital Expenditure | -1.90K | -1.90K | -5.20K | -11.70K | -9.80K |
| Sale of Property, Plant, and Equipment | 1.40K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -500.00 | -1.90K | -5.20K | -11.70K | -9.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.24M | 6.47M | 7.16M | 7.57M | 8.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.74M | -541.80K | -563.10K | 3.76M | 3.69M |
| Cash from Financing | 6.98M | 5.93M | 6.60M | 11.33M | 12.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.18M | -5.03M | -6.01M | -503.80K | 533.50K |